Medicare Enrolled
Dr. Mark Marinella, MD
Hematology & Oncology · Kettering, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Marinella from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Marinella?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Marinella
Dr. Mark Marinella is a hematology & oncology specialist in Kettering, OH, with 21 years of NPI registration. Based on federal Medicare data, Dr. Marinella performed 88,664 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Marinella received a total of $66,114 from 79 pharmaceutical and/or device companies across 414 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Marinella is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 5% volume in OH
$66,114 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗88,664
Medicare services
Top 5% in OH for hematology & oncology
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
20,250 | $1 | $2 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
12,000 | $0 | $1 |
| Pembrolizumab injection (Keytruda) | 12,000 | $42 | $99 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
11,650 | $2 | $8 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
11,000 | $0 | $0 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
5,700 | $0 | $0 |
| Denosumab injection (Prolia/Xgeva) | 4,500 | $18 | $37 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
3,090 | $36 | $86 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
2,690 | $22 | $148 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,516 | $0 | $0 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,110 | $1 | $3 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
329 | $94 | $403 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
276 | $11 | $64 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
240 | $127 | $281 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
219 | $57 | $140 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
182 | $45 | $181 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
174 | $10 | $45 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
167 | $2 | $6 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
136 | $21 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
135 | $88 | $207 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
131 | $1 | $1 |
| Piflufolastat F-18 diagnostic injection A diagnostic injection of the radioactive tracer piflufolastat F-18 used for imaging. The dose specified is 1 millicurie. |
117 | $425 | $1,200 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
101 | $20 | $92 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
93 | $90 | $156 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
93 | $6 | $50 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 88 | $133 | $457 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
71 | $15 | $61 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
60 | $47 | $198 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
55 | $39 | $83 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
52 | $41 | $166 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
49 | $768 | $2,196 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
45 | $24 | $84 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
40 | $61 | $110 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 38 | $586 | $800 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
34 | $53 | $155 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
30 | $79 | $470 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
27 | $146 | $484 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
27 | $38 | $67 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
25 | $1 | $4 |
| New patient office visit, complex (60-74 min) | 23 | $150 | $402 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
23 | $2 | $5 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
19 | $18 | $44 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
18 | $125 | $399 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
15 | $76 | $254 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $118 | $320 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
12 | $100 | $222 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
27.2% high complexity
71.6% medium
1.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$66,114
Total received (2018-2024)
Avg $9,445/year across 7 years
Top 12% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
79
Companies
414
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$25,447
2023
$15,398
2022
$10,388
2021
$13,015
2020
$338
2019
$1,085
2018
$444
Payments by company (2024)
GlaxoSmithKline, LLC.
$21,363
Daiichi Sankyo Inc.
$1,314
AstraZeneca Pharmaceuticals LP
$677
Novartis Pharmaceuticals Corporation
$265
Agios Pharmaceuticals, Inc.
$160
PFIZER INC.
$148
Merck Sharp & Dohme LLC
$130
Celgene Corporation
$116
Incyte Corporation
$104
EMD Serono, Inc.
$96
GENZYME CORPORATION
$85
ABBVIE INC.
$84
TerSera Therapeutics LLC
$76
Stemline Therapeutics Inc.
$68
Gilead Sciences, Inc.
$62
Genentech USA, Inc.
$58
Astellas Pharma US Inc
$57
Cardinal Health 110 LLC
$49
Lilly USA, LLC
$44
BeiGene USA, Inc.
$44
Takeda Pharmaceuticals U.S.A., Inc.
$41
Octapharma USA, Inc.
$38
Kite Pharma, Inc.
$30
Tempus AI, Inc
$29
E.R. Squibb & Sons, L.L.C.
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Aveo Pharmaceuticals, Inc.
$21
Exelixis Inc.
$19
SERVIER PHARMACEUTICALS LLC
$19
MorphoSys, US Inc.
$19
Myriad Genetic Laboratories, Inc.
$19
Sandoz Inc.
$19
Eisai Inc.
$19
Janssen Biotech, Inc.
$17
Deciphera Pharmaceuticals Inc.
$17
ADC Therapeutics America, Inc.
$17
Sirtex Medical Inc
$16
Bayer Healthcare Pharmaceuticals Inc.
$16
SpringWorks Therapeutics, Inc.
$15
Alexion Pharmaceuticals, Inc.
$14
Genmab U.S., Inc.
$14
Top 3 companies account for 91.8% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$27,736
Daiichi Sankyo Inc.
$8,929
Astellas Pharma US Inc
$6,658
GENZYME CORPORATION
$3,332
Novartis Pharmaceuticals Corporation
$2,392
TG THERAPEUTICS, INC.
$2,025
CTI BioPharma Corp.
$1,867
Karyopharm Therapeutics Inc.
$1,623
NOVARTIS PHARMACEUTICALS CORPORATION
$1,575
Janssen Scientific Affairs, LLC
$1,515
Seagen Inc.
$1,262
AstraZeneca Pharmaceuticals LP
$981
EMD Serono, Inc.
$691
E.R. Squibb & Sons, L.L.C.
$511
PFIZER INC.
$387
Gilead Sciences, Inc.
$302
Merck Sharp & Dohme LLC
$295
Celgene Corporation
$249
Amgen Inc.
$246
Incyte Corporation
$236
Janssen Biotech, Inc.
$227
Kite Pharma, Inc.
$219
Pharmacyclics LLC, An AbbVie Company
$200
Merck Sharp & Dohme Corporation
$187
BeiGene USA, Inc.
$180
Agios Pharmaceuticals, Inc.
$160
Alexion Pharmaceuticals, Inc.
$136
Rigel Pharmaceuticals, Inc.
$122
Genentech USA, Inc.
$113
Boehringer Ingelheim Pharmaceuticals, Inc.
$111
Bayer HealthCare Pharmaceuticals Inc.
$104
Takeda Pharmaceuticals U.S.A., Inc.
$99
Octapharma USA, Inc.
$96
Lilly USA, LLC
$90
Myriad Genetic Laboratories, Inc.
$89
ABBVIE INC.
$84
TerSera Therapeutics LLC
$76
Stemline Therapeutics Inc.
$68
Jazz Pharmaceuticals Inc.
$51
Cardinal Health 110 LLC
$49
MorphoSys, US Inc.
$35
Heron Therapeutics, Inc.
$34
Bayer Healthcare Pharmaceuticals Inc.
$34
G1 Therapeutics, Inc.
$34
EISAI INC.
$33
Foundation Medicine, Inc.
$32
Exelixis Inc.
$31
Tempus AI, Inc
$29
Regeneron Healthcare Solutions, Inc.
$26
TESARO, Inc.
$26
Array BioPharma Inc.
$26
Pharmacyclics LLC, an AbbVie Company
$24
Clovis Oncology, Inc.
$24
Mirati Therapeutics, Inc.
$24
Dova Pharmaceuticals
$24
Helsinn Therapeutics (U.S.), Inc.
$22
Aadi Bioscience, Inc.
$22
Spectrum Pharmaceuticals Inc.
$21
Aveo Pharmaceuticals, Inc.
$21
Alnylam Pharmaceuticals Inc.
$20
AVEO Pharmaceuticals, Inc.
$20
SERVIER PHARMACEUTICALS LLC
$19
Sandoz Inc.
$19
Eisai Inc.
$19
TAIHO ONCOLOGY, INC.
$17
Deciphera Pharmaceuticals Inc.
$17
ADC Therapeutics America, Inc.
$17
Kyowa Kirin, Inc.
$16
Ipsen Biopharmaceuticals, Inc
$16
Sirtex Medical Inc
$16
SpringWorks Therapeutics, Inc.
$15
Pharming Healthcare, Inc.
$15
Lexicon Pharmaceuticals, Inc.
$14
Servier Pharmaceuticals LLC
$14
Puma Biotechnology, Inc.
$14
Genmab U.S., Inc.
$14
Sun Pharmaceutical Industries Inc.
$14
PUMA BIOTECHNOLOGY, INC.
$13
EUSA Pharma (US) LLC
$11
Top 3 companies account for 65.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALUNBRIG · BAVENCIO · BLENREP · BOSULIF · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · Cyclophosphamide · DARZALEX · Doptelet · ELIQUIS · ELZONRIS · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · FOTIVDA · FOUNDATIONONE · FRUZAQLA · FYARRO · Fabhalta · GILOTRIF · GIVLAARI · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MYLOTARG · MYRISK · NERLYNX · Nerlynx · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Phesgo · Pomalyst · Poteligeo · QINLOCK · Quzyttir · REBLOZYL · ROLVEDON · RUCONEST · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · Stivarga · Sylvant · TASIGNA · TECVAYLI · TEVIMBRA · TIBSOVO · Tavalisse · Tazverik · Tepmetko · Tibsovo · Tivdak · Trodelvy · UKONIQ · ULTOMIRIS · VALCHLOR · VERZENIO · VOTRIENT · Vanflyta · Venclexta · Vitrakvi · Vonjo · XALKORI · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
40
County median income
$64,403
Nearest hospital to ZIP centroid (approximate)
MIAMI VALLEY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Marinella is a mixed practice specialist, with above-average Medicare volume (top 5% in OH), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Marinella experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Marinella performed 20,250 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Marinella receive payments from pharmaceutical companies?
Yes. Dr. Marinella received a total of $66,114 from 79 companies across 414 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Marinella's costs compare to other hematology & oncology specialists in Kettering?
Dr. Marinella's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Marinella) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Kettering
Browse hematology & oncology specialists in Kettering ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in OH
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in OH
Which OH hematology & oncology specialists receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology